Unclaimed brand
Learn about UPLIZNA® (inebilizumab-cdon) treatment for NMOSD, IgG4-RD, and gMG in adult patients, including the support program, on the official patient website. See safety information.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#823F98
Vivid Violet
130, 63, 152
285, 41, 42
14, 59, 0, 40
#0063C3
Science Blue
0, 99, 195
210, 100, 38
100, 49, 0, 24
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
UPLIZNA is a prescription treatment from Amgen for adults living with certain antibody-positive autoimmune conditions. Its active ingredient is inebilizumab-cdon. The medicine is indicated for adults with neuromyelitis optica spectrum disorder (NMOSD) who test positive for anti-aquaporin-4 antibodies, immunoglobulin G4-related disease (IgG4-RD), and generalized myasthenia gravis (gMG) who test positive for anti-AChR or anti-MuSK antibodies. The website notes that UPLIZNA is not known to be safe or effective in children.
The official UPLIZNA patient website provides condition-specific information, treatment details, Important Safety Information, a Medication Guide, and access to prescribing information. It also introduces a patient support program and shares patient experiences. The site describes UPLIZNA as a treatment designed to fit patients’ lifestyles and states that, after two startup infusions, it is administered twice per year. UPLIZNA was FDA-approved for adults with gMG in 2025. Patients can explore resources for NMOSD, IgG4-RD, and gMG and review safety information with their healthcare team.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
How do I download the UPLIZNA logo?
The UPLIZNA logo comes as a dark logo. Download as SVG or transparent PNG.
What does the UPLIZNA logo look like?
The UPLIZNA wordmark is a bold, uppercase sans-serif name with a registered-mark symbol and no separate emblem.
What are UPLIZNA's brand colors?
The UPLIZNA color palette uses the hex codes #823F98, #0063C3 and #FFFFFF.
Anti-CD19 monoclonal antibody therapy
AQP4-positive NMOSD treatment
IgG4-related disease treatment
Antibody-positive gMG treatment
Rare disease infusion therapy
The UPLIZNA name, logos and brand assets are trademarks of UPLIZNA and its affiliates. Brandfetch isn't affiliated with or endorsed by UPLIZNA. Their use is subject to UPLIZNA's brand guidelines.
